Onkologie. 2012:6(2):85-89

Selected acute conditions among patients enrolled in a programme of the palliative cancer care

Ladislav Slováček1,2, Stanislav Filip1,2, Birgita Slováčková3, Iva Slánská1, Peter Priester1
1 Klinika onkologie a radioterapie FN a LF UK, Hradec Králové
2 Ambulance paliativní onkologické péče Komplexního onkologického centra FN, Hradec Králové
3 Psychiatrická klinika FN a LF UK, Hradec Králové

Medical uninfluenced progression of cancer and previous anticancer therapy, the patient has received are a common cause of sudden

deterioration of general condition. We are talking about a medical emergency and patients impair its overall quality of life, including its

threat to life. The authors deal with its communication of selected acute conditions in patients with end-cancer therapy and included in

the programme of palliative cancer care.

Keywords: palliative cancer care, acute conditions, patient

Published: April 23, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Slováček L, Filip S, Slováčková B, Slánská I, Priester P. Selected acute conditions among patients enrolled in a programme of the palliative cancer care. Onkologie. 2012;6(2):85-89.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Slováček L, Priester P, Kopecký J, Slováčková B, Švecová D, Petera J, Filip S. Paliativní onkologická péče v systému poskytování zdravotní péče v Královehradeckém kraji: vlastní zkušenosti. Klin Onkol 2011; 24: 265-270. Go to PubMed...
    2. Slováček L, Filip S, Šimková M, Priester P, Slánská I, Švecová D, Kopecký J. Ambulance paliativní onkologické péče - její funkce a zařazení v systému poskytování zdravotní péče na regionální úrovni. Paliat Med Lieč Boles 2010; 3(Suppl): 16-18.
    3. Slováček L, Slováčková B, Blažek M, Jebavý L, Kačerovský J. Možnosti paliativní léčby u nemocných v terminálním stádiu maligního onemocnění z pohledu internisty. Prakt Lék 2003; 83: 711-714.
    4. Slováček L, Slováčková B, Blažek M, Jebavý L. Kvalita života onkologických nemocných - definice, koncepce, možnosti měření. Klin Onkol 2006; 19: 163-166.
    5. Basso U, Maruzzo M, Camozzi V, Luisetto G, Lumachi F. Malignant hypercalcemia. Curr med Chem 2011; 18: 3462-3467. Go to original source... Go to PubMed...
    6. Shibata H. Cancer and electrolytes imbalance. Gan To Kagaku Ryoho 2010; 37: 1006-1010.
    7. Sabry NA, Habib EE. Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study. Med Oncol 2011; 28: 584-590. Go to original source... Go to PubMed...
    8. Legrand SB. Modern Management of Malignant Hypercalcemia. Am J Hosp Palliat Care. 2011 Jul 1. Epub ahead of print. Go to original source... Go to PubMed...
    9. Lewis MA, Hendrickson AW, Moynihan TJ. Oncologic emergencies: Pathophysiology, presentation, diagnosis, and treatment. CA Cancer J Clin. 2011 Aug 19. Doi: 10.3322/caac.20124. Go to original source... Go to PubMed...
    10. Morimoto Y, Sugimoto T, Shiozawa H, Hai M, Yokoo Y. Palliative surgery for malignant mediastinal tumor invading the superior vena cava and right atrium. Ann Thorac Surg 2011; 92: 720-722. Go to original source... Go to PubMed...
    11. Rose D, Santo C, Frati G, Bizzarri F. Neoplastic superior vena cava obstruction: combined approach. Eur Rev Med Pharmacol Sci 2011; 15: 577-579. Go to PubMed...
    12. Priester P, Kopecky J, Slovacek L. Malignant thymoma as etiology of bilateral, biventricular cardiac failure. Bratisl Lek Listy 2011; 112: 586-588. Go to PubMed...
    13. Refaat MM, Katz WE. Neoplastic pericardial effusion. Clin Cardiol 2011; 34: 593-598. Go to original source... Go to PubMed...
    14. Retter AS. Pericardial disease in the oncology patient. Heart Dis 2002; 4: 387-391. Go to original source... Go to PubMed...
    15. Zuozhang Y, Lin X, Hongpu S, Yunnchao H, Xiang M, Tao Y, Jinlei Z, Ruilian Z. A patient with T5 metastatic lung cancer and spinal cord compression treated with percutaneous vertebroplasty and iodine-125 seed implantation. Diagn Interv Radiol. 2011 Sep 27. Doi: 10.4261/1305-3825. DIR. 4358-11.1. Go to original source... Go to PubMed...
    16. Yang Z, Yang D, Xie L, Sun Y, Huang Y, Sun H, Liu P, Wu Z. Treatment of metastatic spinal tumors by percutaneous vertebroplasty versus percutaneous vertebroplasty combined with interstitial implantation of 125I seeds. Acta Radiol 2009; 50: 1142-1148. Go to original source... Go to PubMed...
    17. Quraishi NA, Gokaslan ZL, Boriani S. The surgical management of metastatic epidural compression of the spinal cord. J Bone Joint Surg Br 2010; 92: 1054-1060. Go to original source... Go to PubMed...
    18. Elinoff JM, Salit RB, Ackerman HC. The tumor lysis syndrome. N Endl J Med 2011; 365: 571-572, author reply 573-574. Go to original source...
    19. Muslimani A, Chisti MM, Nadeau L, Zakalik D, Daw H, Huang J, Jaivesimi I. How we treat tumor lysis syndrome. Oncology (Williston Park) 2011; 25: 369-375. Go to PubMed...
    20. Sirelkhatim A, Seinova D, Puskacova J, Subova Z, Kaiserova E. Our experience with tumor lysis syndrome treatment. Bratisl Lek Listy 2008; 109: 560-563. Go to PubMed...
    21. Gincu V, Kornprat P, Thimary F, Jahn S, Mischinger HJ. Intestinal obstruction caused by splenosis at the rectosigmoid junction, mimicking malignant pelvic tumor. Endoscopy 2011; 43: E260. Go to original source... Go to PubMed...
    22. Lepsenyi M, Santen S, Syk I, Nielsen J, Nemeth A, Toth E, Thorlacius H. Self-expanding metal stents in malignant colonic obstruction: experiences from Sweden. BMC Res Notes 2011; 30: 274. Go to original source... Go to PubMed...
    23. Kabelka L, Sláma O. Syndrom maligní střevní obstrukce. In. Sláma O, Kabelka L, Vorlíček J, et al. Paliativní medicína pro praxi. Praha, Galén 2007: 123-124.
    24. Řehoušková K, Toušek F, Pavlíčková N. Plicní embolie jako paraneoplastický projev melanomu cévnatky. Prakt Lék 2011; 91: 103-105.
    25. Piccioli A, Prandoni P. Approach to venous thromboembolism in the cancer patient. Curr Treat Options Cardiovasc Med 2011; 13: 159-168. Go to original source... Go to PubMed...
    26. Prandoni P. The treatment of venous thromboembolism in patients with cancer. Intern Emerg Med 2010; 5: S27-S30. Go to original source... Go to PubMed...
    27. Noble S, Pasi J. Epidemiology and pathophysiology of cancer-associated thrombosis. Br J Cancer 2010; 102: S2-S9. Go to original source... Go to PubMed...
    28. Blažková S. Hematologické aspekty paliativní péče. In. Sláma O, Kabelka L, Vorlíček J, et al. Paliativní medicína pro praxi. Praha, Galén 2007: 157-161.
    29. Vaughn C, Zhang L, Schiff D. Reversible posterior leukoencephalopathy syndrome in cancer. Curr Oncol Rep 2008; 10: 86-91. Go to original source... Go to PubMed...
    30. Wong ET, Yamaguchi NH. Treatment advances for glioblastoma. Expert Rev Neurother 2011; 11: 1343-1345. Go to original source... Go to PubMed...
    31. Krijtová H, Marusič P. První epileptický záchvat - diagnostický postup a indikace k zahájení terapie. Neurol. pro praxi 2010; 11: 386-390.
    32. Prayson RA. Brain tumors in adults with medically intractable epilepsy. Am J Clin Pathol 2011; 136: 557-563. Go to original source... Go to PubMed...
    33. Miabi Z. Metastatic brain tumors: a retrospective review in East Azarbyjan (Tabriz). Acta Med Iran 2011; 49: 115-117.
    34. Kallel A, Bailon O, Carpentier AF. Clinical symptoms and symptomatic management of brain metastases. Bull Cancer 2011; 98: 371-375. Go to original source... Go to PubMed...
    35. Gofton TE. Delirium: a review. Can J Neurol Sci 2011; 38: 673-680. Go to original source... Go to PubMed...
    36. Mori M, Parsons HA, De La Cruz M, Elsayem A, Palla SL, Liu J, Li Z, Palmer L, Pruera E, Fadul NA. Changes in symptoms and inpatient mortality: a study in advanced cancer patients admitted to an acute palliative care unit in a comprehensive cancer center. J Palliat Med 2011; 14: 1034-1041. Go to original source... Go to PubMed...
    37. Derby S. Assessment and management of delirium in the older adult with cancer. Clin J Oncol Nurs 2011; 15: 247-250. Go to original source... Go to PubMed...
    38. Galanakis C, Mayo NE, Gagnon B. Assessing the role of hydration in delirium at the end of life. Curr Opin Support Palliat Care 2011; 5: 139-173. Go to original source... Go to PubMed...
    39. Clegg A, Young JB., ,Which medications to avoid in people at risk of delirium: a systematic review". Age and ageing 2011; 40: 23-29. Go to original source... Go to PubMed...
    40. Krome S. Cancer pain management: The WHO's analgesic ladder as guideline. Dtsch Med Wochenschr 2011; 136: S94-S96. Go to original source... Go to PubMed...
    41. Rana S, Gupta R, Chaudhary P, Khurana D, Mishra S, Bhatnagar S. Cancer pain management: basic information for the young pain physicians. Indian J Palliat Care 2011; 17: 127-130. Go to original source... Go to PubMed...
    42. Gangi A, Buy X, Garnon J, Tsoumakidou G, Moser T, Bierry G, Muller A. Pain management in oncology. J Radiol 2011; 92: 801-813. Go to original source... Go to PubMed...
    43. Sláma O. Léčba průlomové bolesti u onkologických pacientů. Farmakoterapie 2010; 5: 555-561.
    44. Kabelka L, Kozák J, Lejčko J, Sláma O. Doporučený postup pro léčbu průlomové nádorové bolesti. Bolest 2011; 14: P1-P5.
    45. Sláma O, Lejčko J, Kozák J, Kabelka L, Vorlíček J, Fínek J, Slováček L, Duba J, Ryšavá L. Epidemiologie a léčba průlomové bolesti u onkologických pacientů v ČR - výsledky výzkumného projektu PARMA. Část 2. Léčba průlomové bolesti a spokojenost pacientů s léčbou. Bolest 2011; 14: 91-95.
    46. Slováček L, Šimková M, Petera J, Filip S. Může pacient v terminálním stádiu onkologického onemocnění důstojně zemřít doma? A za jakých podmínek? Klin Onkol 2011; 24(3): 221-223. Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.